140 related articles for article (PubMed ID: 7574833)
1. Reproducible measurements to quantify cutaneous involvement in scleroderma.
Aghassi D; Monoson T; Braverman I
Arch Dermatol; 1995 Oct; 131(10):1160-6. PubMed ID: 7574833
[TBL] [Abstract][Full Text] [Related]
2. Durometry for the assessment of skin disease in systemic sclerosis.
Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
[TBL] [Abstract][Full Text] [Related]
3. Period of remission after treatment with UVA-1 in sclerodermic skin diseases.
Kroft EB; van de Kerkhof PC; Gerritsen MJ; de Jong EM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):839-44. PubMed ID: 18452527
[TBL] [Abstract][Full Text] [Related]
4. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients.
Sato LT; Kayser C; Andrade LE
Acta Reumatol Port; 2009; 34(2A):219-27. PubMed ID: 19474777
[TBL] [Abstract][Full Text] [Related]
5. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
Kissin EY; Merkel PA; Lafyatis R
Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
[TBL] [Abstract][Full Text] [Related]
6. The presence of dominant T-cell clones in peripheral blood of patients with collagen vascular disorders: a prospective study of 97 cases.
Dereure O; Gubler B; Bessis D; Guillot B; Guilhou JJ; Clot J; Eliaou JF
Br J Dermatol; 2006 Mar; 154(3):445-9. PubMed ID: 16445773
[TBL] [Abstract][Full Text] [Related]
7. Laser doppler imaging--a new technique for quantifying microcirculatory flow in patients with primary Raynaud's phenomenon and systemic sclerosis.
Clark S; Campbell F; Moore T; Jayson MI; King TA; Herrick AL
Microvasc Res; 1999 May; 57(3):284-91. PubMed ID: 10329254
[TBL] [Abstract][Full Text] [Related]
8. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
Steen VD; Medsger TA
Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
[TBL] [Abstract][Full Text] [Related]
9. [Objective evaluation of sclerodermic skin using the slip-test. Results and validation with 30 patients and 60 controls].
Bennis R; Cabane J; Giral P; Blétry O; Chaibi P; Wattiaux MJ; Picard O; Lebas J; Imbert JC; Godeau P
Ann Med Interne (Paris); 1992; 143(8):510-4. PubMed ID: 1303593
[TBL] [Abstract][Full Text] [Related]
10. Maximum blood flow and microvascular regulatory responses in systemic sclerosis.
Gunawardena H; Harris ND; Carmichael C; McHugh NJ
Rheumatology (Oxford); 2007 Jul; 46(7):1079-82. PubMed ID: 17494087
[TBL] [Abstract][Full Text] [Related]
11. Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging--a non-invasive technique by which to measure microvascular dysfunction in Raynaud's phenomenon.
Anderson ME; Moore TL; Lunt M; Herrick AL
Rheumatology (Oxford); 2004 Aug; 43(8):986-91. PubMed ID: 15199217
[TBL] [Abstract][Full Text] [Related]
12. Sodium nitroprusside iontophoresis on the finger pad does not consistently increase skin blood flow in healthy controls and patients with systemic sclerosis.
Roustit M; Blaise S; Cracowski JL
Microvasc Res; 2009 May; 77(3):260-4. PubMed ID: 19272396
[TBL] [Abstract][Full Text] [Related]
13. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis.
Davies CA; Jeziorska M; Freemont AJ; Herrick AL
Rheumatology (Oxford); 2006 Nov; 45(11):1349-55. PubMed ID: 17050587
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity.
Caramaschi P; Canestrini S; Martinelli N; Volpe A; Pieropan S; Ferrari M; Bambara LM; Carletto A; Biasi D
Rheumatology (Oxford); 2007 Oct; 46(10):1566-9. PubMed ID: 17693443
[TBL] [Abstract][Full Text] [Related]
15. Hyperplasia of dermal microvascular pericytes in scleroderma.
Helmbold P; Fiedler E; Fischer M; Marsch WCh
J Cutan Pathol; 2004 Jul; 31(6):431-40. PubMed ID: 15186431
[TBL] [Abstract][Full Text] [Related]
16. Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
Merkel PA; Silliman NP; Denton CP; Furst DE; Khanna D; Emery P; Hsu VM; Streisand JB; Polisson RP; Akesson A; Coppock J; van den Hoogen F; Herrick A; Mayes MD; Veale D; Seibold JR; Black CM; Korn JH; ;
Arthritis Rheum; 2008 May; 59(5):699-705. PubMed ID: 18438905
[TBL] [Abstract][Full Text] [Related]
17. Increased 133xenon washout from cutaneous tissue in generalized scleroderma indicates increased blood flow.
Kristensen JK; Wadskov S
Acta Derm Venereol; 1978; 58(4):313-7. PubMed ID: 82324
[TBL] [Abstract][Full Text] [Related]
18. Assessment of abnormal blood flow and efficacy of treatment in patients with systemic sclerosis using a newly developed microwireless laser Doppler flowmeter and arm-raising test.
Kido M; Takeuchi S; Hayashida S; Urabe K; Sawada R; Furue M
Br J Dermatol; 2007 Oct; 157(4):690-7. PubMed ID: 17640308
[TBL] [Abstract][Full Text] [Related]
19. Blunted increase of digital skin vasomotion following acetylcholine and sodium nitroprusside iontophoresis in systemic sclerosis patients.
Rossi M; Bazzichi L; Di Maria C; Franzoni F; Raimo K; Della Rossa A; Santoro G; Bombardieri S
Rheumatology (Oxford); 2008 Jul; 47(7):1012-7. PubMed ID: 18430760
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
Poormoghim H; Lucas M; Fertig N; Medsger TA
Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
